616461 Sigma-AldrichTGF-β RI Kinase Inhibitor VI, SB431542 - CAS 301836-41-9 - Calbiochem
TGF-β RI Kinase Inhibitor VI, SB431542, CAS 301836-41-9, is a cell-permeable inhibitor of SMAD2 phosphorylation. Inhibits the activity of ALK4 and ALK5 (IC₅₀ = 140 nM and 94 nM, respectively).
More>> TGF-β RI Kinase Inhibitor VI, SB431542, CAS 301836-41-9, is a cell-permeable inhibitor of SMAD2 phosphorylation. Inhibits the activity of ALK4 and ALK5 (IC₅₀ = 140 nM and 94 nM, respectively). Less<<Synonyms: 4-[4-(3,4-Methylenedioxyphenyl)-5-(2-pyridyl)-1H-imidazol-2-yl]benzamide, Dihydrate, 4-[4-(1,3-Benzodioxol-5-yl)-5-(2-pyridyl)-1H-imidazol-2-yl]benzamide, Dihydrate, SB-431542
Recommended Products
Overview
Replacement Information |
---|
Key Spec Table
CAS # | Empirical Formula |
---|---|
301836-41-9 | C₂₂H₁₆N₄O₃. 2H₂O |
Pricing & Availability
Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
---|---|---|---|---|---|---|
616461-5MG |
|
5 mg |
|
— |
Description | |
---|---|
Overview | A cell-permeable triarylimidazole compound that is shown to effectively inhibit cellular Smad2 phosphorylation (>90% inhibition by 10 µM inhibitor) upon vector-mediated expression of constitutively active ALK4, ALK5, or ALK7 in NIH 3T3 cells, while exhibiting little effect against Smad1 phosphorylation by other members of type I receptors for TGF-β in NIH 3T3 cultures expressing active ALK1, 2, 3, or 6. When tested directly in cell-free kinase assays, SB431542 is demonstrated to potently inhibit the activity of ALK4 and ALK5 (IC50 = 140 nM and 94 nM, respectively) with no or much reduced potency toward a panel of 24 other kinases (IC50 ≥10 µM in the presence of 10 µM ATP), including ALK2 and ALK6. Reported to improve the efficiency of 4-TF-induced human iPSCs generation from fibroblast cultures by >200-fold when used together with PD0325901 (Cat. No. 444966) and Thiazovivin (Cat. No. 420220). Also available as a 100 mM solution in DMSO (Cat. No. 616464). |
Catalogue Number | 616461 |
Brand Family | Calbiochem® |
Synonyms | 4-[4-(3,4-Methylenedioxyphenyl)-5-(2-pyridyl)-1H-imidazol-2-yl]benzamide, Dihydrate, 4-[4-(1,3-Benzodioxol-5-yl)-5-(2-pyridyl)-1H-imidazol-2-yl]benzamide, Dihydrate, SB-431542 |
Product Information | |
---|---|
CAS number | 301836-41-9 |
Form | Off-white solid |
Hill Formula | C₂₂H₁₆N₄O₃. 2H₂O |
Chemical formula | C₂₂H₁₆N₄O₃. 2H₂O |
Structure formula Image | |
Quality Level | MQ300 |
Applications |
---|
Biological Information | |
---|---|
Purity | ≥97% by HPLC |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalogue Number | GTIN |
616461-5MG | 04055977185928 |
Documentation
TGF-β RI Kinase Inhibitor VI, SB431542 - CAS 301836-41-9 - Calbiochem SDS
Title |
---|
TGF-β RI Kinase Inhibitor VI, SB431542 - CAS 301836-41-9 - Calbiochem Certificates of Analysis
Title | Lot Number |
---|---|
616461 |
References
Reference overview |
---|
Ikushima, H., et al. 2009. Cell Stem Cell 5, 504. Lin, T., et al. 2009. Nat. Methods 6, 805. Maherali, N. and Hochedlinger, K., 2009. Curr. Biol. 19, 1718. Callahan, J.F., et al. 2002. J. Med. Chem. 45, 999. Inman, G.J., et al. 2002. Mol. Pharmacol. 62, 65. Laping, N.J., et al. 2002. Mol. Pharmacol. 62, 58. |